The one-size-fits-all approach to pain management should be a thing of the past. But we’re still not there yet.
Non-opioid pain therapies are entering an unprecedented era, marked by the landmark FDA approval of Vertex’s Journavx and a ...
Beginning March 1st a new state law will require veterinarians to report prescriptions of Gabapentin to the state.
The apex drug regulatory authority has prohibited the production and export of all combinations of pain relief medicines tapentadol and carisoprodol, over news reports that unapproved combinations of ...
The meeting comes following the Drugs Controller General of India (DCGI) decision to prohibit the production and export of all combinations of pain relief medicines tapentadol and carisoprodol.
Not all chest pain indicates a heart attack. Learn to distinguish between life-threatening cardiac emergencies and less ...
Shoulder symptoms led to an average of 9.6 million physician visits in 2015 and 2016 in the United States. The most common ...
Initial feasibility study of its soluble, Ph neutral, fast acting granular or powder drug delivery system is complete ...
From running out of pills too soon to doctor shopping, learn the red flags of pain medication dependency and where to find ...
Compared with placebo, zavegepant nasal spray yielded sustained relief of acute pain and function in migraine.
The US FDA has approved Journavx, a new pain reliever without the risks for addiction or overdose linked to drugs like Vicodin and OxyContin.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback